James Monslow

3.1k total citations · 1 hit paper
25 papers, 1.7k citations indexed

About

James Monslow is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, James Monslow has authored 25 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Immunology. Recurrent topics in James Monslow's work include Peptidase Inhibition and Analysis (7 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Wound Healing and Treatments (3 papers). James Monslow is often cited by papers focused on Peptidase Inhibition and Analysis (7 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Wound Healing and Treatments (3 papers). James Monslow collaborates with scholars based in United States, United Kingdom and Norway. James Monslow's co-authors include Ellen Puré, Priya Govindaraju, Leslie Todd, Diana Avery, Elizabeth L. Buza, Albert Lo, Amy C. Durham, Steven Μ. Albelda, David J. Bajor and Michele H. Jacob and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and The Journal of Immunology.

In The Last Decade

James Monslow

25 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells

2015 407 citations Albert Lo, Liang‐Chuan S. Wang et al. Cancer Research profile →

Peers

Countries citing papers authored by James Monslow

Since Specialization

Citations

This map shows the geographic impact of James Monslow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Monslow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Monslow more than expected).

Fields of papers citing papers by James Monslow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Monslow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Monslow. The network helps show where James Monslow may publish in the future.

Co-authorship network of co-authors of James Monslow

This figure shows the co-authorship network connecting the top 25 collaborators of James Monslow. A scholar is included among the top collaborators of James Monslow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Monslow. James Monslow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	T-bet–expressing B cells promote atherosclerosis in apolipoprotein E–deficient mice 2025 ·The Journal of Immunology ·James J. Knox, (unknown), James Monslow, Debra Cromley, Daniel J. Rader, Ellen Puré, Michael P. Cancro	1
2	A machine learning approach toward automating spatial identification of LAG3+/CD3+ cells in ulcerative colitis 2023 ·Scientific Reports ·Edward D. Bonnevie, Eric Dobrzynski, (unknown), (unknown), James Monslow, (unknown), Vilma Decman, David Krull	1
3	Fibroblast Activation Protein Regulates Lesion Burden and the Fibroinflammatory Response in Apoe-Deficient Mice in a Sexually Dimorphic Manner 2020 ·American Journal Of Pathology ·James Monslow, Leslie Todd, (unknown), Priya Govindaraju, Richard K. Assoian, Ellen Puré	15
4	Abstract A62: Inhibition of tumor growth by novel CART redirected against cells expressing high levels of fibroblast activation protein 2020 ·Cancer Immunology Research ·Estela Noguera-Ortega, Leslie Todd, James Monslow, Jing Sun, Steven Μ. Albelda, Ellen Puré	1
5	Deletion of Calcineurin Promotes a Protumorigenic Fibroblast Phenotype 2019 ·Cancer Research ·(unknown), Richard Barrett, Jaewon Kim, (unknown), Diana Avery, James Monslow, Hyunsoo Kim, Bang‐Jin Kim, Ellen Puré, Sandra Ryeom	6
6	Cardiovascular protection in females linked to estrogen-dependent inhibition of arterial stiffening and macrophage MMP12 2019 ·JCI Insight ·Shu‐Lin Liu, Anamika Bajpai, Elizabeth A. Hawthorne, Yongho Bae, Paola A. Castagnino, James Monslow, Ellen Puré, Kara L. Spiller, Richard K. Assoian	40
7	Loss of cells expressing fibroblast activation protein has variable effects in models of TGF-β and chronic bleomycin-induced fibrosis 2019 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Tōru Kimura, James Monslow, Astero Klampatsa, Michael S. Leibowitz, Jing Sun, Maria Liousia, (unknown), Edmund K. Moon, Leslie Todd, Ellen Puré, Steven Μ. Albelda	25
8	The CD44-HA axis and inflammation in atherosclerosis: A temporal perspective 2018 ·Matrix Biology ·(unknown), James Monslow, Ellen Puré	70
9	CD44-dependent inflammation, fibrogenesis, and collagenolysis regulates extracellular matrix remodeling and tensile strength during cutaneous wound healing 2018 ·Matrix Biology ·Priya Govindaraju, Leslie Todd, Snehal S. Shetye, James Monslow, Ellen Puré	123
10	Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts 2017 ·Matrix Biology ·Diana Avery, Priya Govindaraju, Michele H. Jacob, Leslie Todd, James Monslow, Ellen Puré	151
11	Identification of prognostic collagen signatures and potential therapeutic stromal targets in canine mammary gland carcinoma 2017 ·PLoS ONE ·Ashley S. Case, Becky K. Brisson, Amy C. Durham, (unknown), James Monslow, Elizabeth L. Buza, (unknown), (unknown), Gordon Ruthel, (unknown), Veronica Kristiansen, Ellen Puré, Dorothy Cimino Brown, Karin U. Sørenmo, Susan W. Volk	39
12	Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma 2017 ·JCI Insight ·Albert Lo, Chung‐Pin Li, Elizabeth L. Buza, Rachel Blomberg, Priya Govindaraju, Diana Avery, James Monslow, Michael Hsiao, Ellen Puré	114
13	Cardiovascular Consequences of Prostanoid I Receptor Deletion in Microsomal Prostaglandin E Synthase-1–Deficient Hyperlipidemic Mice 2016 ·Circulation ·Soon Yew Tang, James Monslow, Gregory R. Grant, Leslie Todd, Sven‐Christian Pawelzik, Lihong Chen, John A. Lawson, Ellen Puré, Garret A. FitzGerald	20
14	Hyaluronan â€“ A Functional and Structural Sweet Spot in the Tissue Microenvironment 2015 ·Frontiers in Immunology ·James Monslow, Priya Govindaraju, (unknown)	141
15	Matrix metalloproteinase-12 is an essential mediator of acute and chronic arterial stiffening 2015 ·Scientific Reports ·Shu‐Lin Liu, Yongho Bae, Christopher Yu, James Monslow, Elizabeth A. Hawthorne, Paola A. Castagnino, Emanuela Branchetti, Giovanni Ferrari, Scott M. Damrauer, Ellen Puré, Richard K. Assoian	46
16	Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells breakdown → 2015 ·Cancer Research ·Albert Lo, Liang‐Chuan S. Wang, John Scholler, James Monslow, Diana Avery, Kheng Newick, Shaun O’Brien, Rebecca A. Evans, David J. Bajor, Cynthia Clendenin, Amy C. Durham, Elizabeth L. Buza, Robert H. Vonderheide, Carl H. June, Steven Μ. Albelda, Ellen Puré	407
17	Cyclooxygenase-2 in Endothelial and Vascular Smooth Muscle Cells Restrains Atherogenesis in Hyperlipidemic Mice 2014 ·Circulation ·Soon Yew Tang, James Monslow, Leslie Todd, John A. Lawson, Ellen Puré, Garret A. FitzGerald	50
18	Cardiovascular Protection by ApoE and ApoE-HDL Linked to Suppression of ECM Gene Expression and Arterial Stiffening 2012 ·Cell Reports ·Devashish Kothapalli, Shu‐Lin Liu, Yongho Bae, James Monslow, Tina Xu, Elizabeth A. Hawthorne, Fitzroy J. Byfield, Paola A. Castagnino, Shilpa Rao, Daniel J. Rader, Ellen Puré, Michael C. Phillips, Sissel Lund‐Katz, Paul A. Janmey, Richard K. Assoian	148
19	Wounding-Induced Synthesis of Hyaluronic Acid in Organotypic Epidermal Cultures Requires the Release of Heparin-Binding EGF and Activation of the EGFR 2009 ·Journal of Investigative Dermatology ·James Monslow, Nobuyuki Sato, Judith A. Mack, Edward V. Maytin	39
20	Secretion of Oncostatin M by Infiltrating Neutrophils: Regulation of IL-6 and Chemokine Expression in Human Mesothelial Cells 2002 ·The Journal of Immunology ·Suzanne M. Hurst, Rachel M. McLoughlin, James Monslow, (unknown), (unknown), Gerald M. Fuller, Nicholas Topley, Simon A. Jones	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact